AprilDavis

CD BioGlyco Released An Advanced Platform for Glycogenomics

CD BioGlyco, a leading provider of glycobiology research services, is proud to announce the release of its advanced glycogenomics platform. This platform integrates cutting-edge technologies and expertise to provide comprehensive solutions for glycogene editing, expression profiling, and disease-related research. Glycogenomics is a rapidly evolving field that combines genomics and glycomics to study the complex networks of…

Read More

Genetic Variants May Disrupt Myelin Production

Among Alzheimer ‘s victims, 40% to 65% have a genetic variant called APOE4. Scientists have long known that this variant significantly increases the risk of neurodegenerative diseases, especially when one inherits a copy of APOE4 from both parents, but they are still learning to explain the molecular mechanisms of APOE4 action.   A study published…

Read More